These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 22185812
1. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors. Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB. Hum Vaccin; 2011 Dec; 7(12):1293-8. PubMed ID: 22185812 [Abstract] [Full Text] [Related]
2. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP. Ann Rheum Dis; 2008 May; 67(5):713-6. PubMed ID: 17965123 [Abstract] [Full Text] [Related]
3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
4. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730 [Abstract] [Full Text] [Related]
5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep 17; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
7. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Mamula P, Markowitz JE, Piccoli DA, Klimov A, Cohen L, Baldassano RN. Clin Gastroenterol Hepatol; 2007 Jul 17; 5(7):851-6. PubMed ID: 17544875 [Abstract] [Full Text] [Related]
8. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Rheumatology (Oxford); 2007 Apr 17; 46(4):608-11. PubMed ID: 17114801 [Abstract] [Full Text] [Related]
9. Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM. Ann Rheum Dis; 2011 Dec 17; 70(12):2144-7. PubMed ID: 21859696 [Abstract] [Full Text] [Related]
10. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
11. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM, Song JY, Hwang IS, Lee J, Oh SC, Kim JS, Kim SR, Kim WJ, Cheong HJ. J Med Virol; 2009 Apr 27; 81(4):722-7. PubMed ID: 19235853 [Abstract] [Full Text] [Related]
12. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Torii Y, Kimura H, Ochi N, Kaneko K, Ando H, Kiuchi T, Ito Y. Vaccine; 2011 Jun 06; 29(25):4187-9. PubMed ID: 21513762 [Abstract] [Full Text] [Related]
13. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Cullen G, Bader C, Korzenik JR, Sands BE. Gut; 2012 Mar 06; 61(3):385-91. PubMed ID: 21757451 [Abstract] [Full Text] [Related]
14. Immune response after influenza vaccination in children with cancer. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Pediatr Blood Cancer; 2005 Nov 06; 45(6):831-7. PubMed ID: 16007602 [Abstract] [Full Text] [Related]
15. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children. Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S. Medicina (B Aires); 2007 Nov 06; 67(4):351-9. PubMed ID: 17891930 [Abstract] [Full Text] [Related]
16. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M. Clin Immunol; 2010 Aug 06; 136(2):228-35. PubMed ID: 20421178 [Abstract] [Full Text] [Related]
17. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ. J Infect Dis; 2009 Sep 15; 200(6):849-57. PubMed ID: 19673652 [Abstract] [Full Text] [Related]
18. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer. Yen TY, Jou ST, Yang YL, Chang HH, Lu MY, Lin DT, Lin KH, Huang LM, Chang LY. Pediatr Blood Cancer; 2011 Dec 15; 57(7):1154-8. PubMed ID: 21425448 [Abstract] [Full Text] [Related]
19. Immunogenicity and safety of intradermal influenza vaccine in children. Esposito S, Daleno C, Picciolli I, Tagliaferri L, Scala A, Prunotto G, Montinaro V, Galeone C, Principi N. Vaccine; 2011 Oct 13; 29(44):7606-10. PubMed ID: 21855592 [Abstract] [Full Text] [Related]
20. H1N1 vaccination in pediatric renal transplant patients. Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ. Transplant Proc; 2011 May 13; 43(4):1244-6. PubMed ID: 21620100 [Abstract] [Full Text] [Related] Page: [Next] [New Search]